A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
With 4 hospitals and 3,400 beds, the Assistance Publique – Hôpitaux de Marseille (AP-HM) is the 3rd University Hospital Center in France. It is also the leading employer in the region, with more than 12,000 employees and nearly 2,000 doctors. Its missions are care, training, research as well as prevention and health education.
Marseille, France Clinical Trial Location
278 Rue Saint-Pierre,
13005 Marseille, France